throbber
WO 98/33939
`
` PCT/JP97/00239
`
`World Intellectual Property Organization
`International Office
`International Application Laid Open [WIPO seal]
`According to Patent Cooperation Treaty
`(51) Int’l Patent Classification 6
`(11) Int’l KOKAI No.
`C12Q 1/68, C12M 1/00, G01N 33/50,
`C12N 15/10
`(21) Int’l Application No.
`
` WO98/33939
`
`(43) Int’l KOKAI Date
` August 6,1998
`(81) Designated countries: CN, JP, KR, US, European
`Patent (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT,
`LU, MC, NL, PT, SE).
`
`Attached KOKAI documents
` International Search Report
`
`PCT
`
`A1
`
` PCT/JP97/00239
`
`(22) Int’l Application Date
` January 31, 1997
`(71) Applicant (all countries except the United States)
`Hitachi, Ltd. [JP/JP] 4-6 Kanda Surugadai, Chiyoda-ku,
`Tokyo 101 (JP)
`(72) Inventor; and
`(75) Inventor/Applicant (the United States only)
`ANAZAWA, Takeshi [JP/JP]
`UEMATSU, Chihiro [JP/JP]
`3-8-1 Koigakubo, Kokubunji-shi, Tokyo 185 (JP)
`OKANO, Kazunori [JP/JP]
`5-17-2-402 Honcho, Shiki-shi, Saitama-ken 353 (JP)
`KAMBARA, Hideki [JP/JP]
`1-4-3 Kitanodai, Hachioji-shi, Tokyo 192 (JP)
`(74) Agent
`OGAWA, Katsuo, patent attorney
`c/o Hitachi, Ltd., Tokyo (JP)
`1-5-1 Marunouchi, Chiyoda-ku, Tokyo 100
`
`(54) Title of Invention: Method for Determining Nucleic Acid Base Sequences and Apparatus for Determining Nucleic
`Acid Base Sequences
`
`Illumina, Inc.
`Exhibit No. 1011
`
`Page 1
`
`Illumina Ex. 1073
`IPR Petition - USP 10,435,742
`
`

`

`WO 98/33939 PCT/JP97/00239
`
`
`(57) Abstract
`
`
`
` A single molecule of single-stranded sample DNA (7) having a bead (5) at one end
`thereof and a magnetic bead (6) at the other end thereof is elongated and fixed in the
`field of view of a fluorescence microscope by a magnetic force (11) and a laser trap (3),
`a primer (8) is bound thereto, and an elongation reaction (10) is conducted with
`polymerase. Only a single chemically modified nucleotide (9) that is labeled with a
`fluorophore that is different for each base type is incorporated. Only the single
`fluorophore incorporated is measured, by evanescent irradiation from an ultraviolet
`laser (2), as a fluorescence microscopic image, and the base type is determined from the
`fluorophore type. By the evanescent irradiation (13) from the excitation laser (1), the
`fluorophore that labels the incorporated nucleotide is released, and the next nucleotide
`is incorporated. DNA base sequences are determined by repeating this process. Base
`sequence determination can be performed using a single DNA molecule, and base
`sequences can be efficiently determined for DNA having several hundreds of thousands
`of bases or more.
`------------------------------------------------------------------------------------------------------------------------------
`
`Codes used for identifying PCT member nations listed on page 1 of the pamphlet for the
`international application laid open on the basis of the PCT (reference information)
`AL Albania
`DK Denmark
`KZ Kazakhstan
`PT Portugal
`AM Armenia
`EE Estonia
`LC Saint Lucia
`RO Romania
`AT Austria
`ES Spain
`LI Liechtenstein
`RU Russian Federation
`AU Australia
`FI Finland
`LK Sri Lanka
`SD Sudan
`AZ Azerbaijan
`FR France
`LR Liberia
`SE Sweden
`BA Bosnia and
`GA Gabon
`LS Lesotho
`SG Singapore
`Herzegovina
`GB United Kingdom
`LT Lithuania
`SI Slovenia
`BB Barbados
`GE Georgia
`LU Luxembourg
`SK Slovakia
`BE Belgium
`GH Ghana
`LV Latvia
`SL Sierra Leone
`BF Burkina Faso
`GM Gambia
`MC Monaco
`SN Senegal
`BG Bulgaria
`GN Guinea
`MD Republic of
`SZ Swaziland
`BJ Benin
`GW Guinea-Bissau
`Moldova
`TD Chad
`BR Brazil
`GR Greece
`MG Madagascar
`TG Togo
`BY Belarus
`HU Hungary
`MK The former
`TJ Tajikistan
`CA Canada
`ID Indonesia
`Yugoslav Republic
`TM Turkmenistan
`CF Central African
`IE Ireland
`of Macedonia
`TR Turkey
`Republic
`IL Israel
`ML Mali
`TT Trinidad and
`CG Congo
`IS Iceland
`MN Mongolia
`Tobago
`CH Switzerland
`IT Italy
`MR Mauritania
`UA Ukraine
`CI Côte d'Ivoire
`JP Japan
`MW Malawi
`UG Uganda
`CM Cameroon
`KE Kenya
`MX Mexico
`US United States of
`CN China
`KG Kyrgyzstan
`NE Niger
`America
`CU Cuba
`KP Democratic
`NL Netherlands
`UZ Uzbekistan
`CY Cyprus
`People’s Republic
`NO Norway
`VN Viet Nam
`CZ Czech Republic
`of Korea
`NZ New Zealand
`YU Yugoslavia
`DE Germany
`KR Republic of Korea
`PL Poland
`ZW Zimbabwe
`
`
`
`
`Exhibit No. 1011
`Page 2
`
`Page 2
`
`

`

`WO 98/33939 PCT/JP97/00239
`1
`
`Specification
`
`Method for Determining Nucleic Acid Base Sequences and Apparatus for Determining
`Nucleic Acid Base Sequences
`
`Technical Field
`
`This invention relates to an apparatus for analyzing DNA and RNA and the like, and
`more particularly to an apparatus that is effective for determining DNA and RNA base
`sequences or, alternatively, analyzing limited enzyme fragments or specific fragments.
`
`Technical Background
`
`Techniques for analyzing DNA, RNA, and the like are important in the fields of
`
`medicine and biology, inclusive of gene analysis and genetic diagnosis. The determination
`or DNA and RNA base sequences, and the analysis of limited enzyme fragments and
`specific fragments, are both based on separation by molecular weight by electrophoresis. A
`fragment or fragment group is subjected beforehand to radioactive labeling or fluorescent
`labeling, and, after conducting electrophoresis, or during electrophoresis, analysis is
`effected by measuring molecular weight-separation development patterns. Recently, in
`connection with genome analysis, the demand for DNA base sequence determining
`apparatuses, in particular, has grown, and the development of such devices is on-going.
`DNA base sequence determination using fluorescent labeling is now described. Prior to
`electrophoretic separation, a dideoxy reaction is carried out by the Sanger method. A
`nucleotide having a length of approximately 20 bases that is complementary to a known
`portion of the base sequence of the sample DNA to be analyzed is synthesized and labeled
`with a fluorophore [lit. a fluorophore is labeled]. This oligonucleotide is complementary-
`chain bound to approximately 10í12 mol of the sample DNA as a primer, and a
`complementary chain elongation reaction is conducted using polymerase. At this time, four
`deoxynucleotide triphosphates are added as substrates, namely deoxyadenosine
`triphosphate (dATP), deoxycytidine triphosphate (dCTP), deoxyguanosine triphosphate
`(dGTP), deoxythymidine (dTTP), and, in addition thereto, dideoxyadenosie triphosphate
`(ddATP). When ddATP is incorporated by complementary-chain elongation, because the
`complementary chain is not elongated beyond that, fragments of various lengths and
`terminated by adenine (A) are prepared. Reactions are conducted independently wherein,
`instead of ddATP in the reaction noted above, dideoxycytidine triphosphate (ddCTP),
`dideoxyguanosine triphosphate (ddGTP), and dideoxyguanosine triphosphate (ddTTP),
`respectively, are added. However, while the primers used in each reaction have the same
`base sequence, four types of fluorophores, which can be mutually distinguished by
`separating fluorescence, are used for labeling [lit. are labeled].
` When the four types of reactant noted above are mixed, fragments complementary to
`the sample DNA, having a length of up to approximately 1000 bases, and with lengths
`differing one base at a time, are prepared, with four types of fluorophores being used in
`labeling [lit. labeled], according to the terminal base type. The number of fragments of
`each base length, respectively, is approximately 10í15 mol. Next, the samples prepared are
`
`Exhibit No. 1011
`Page 3
`
`Page 3
`
`

`

`WO 98/33939 PCT/JP97/00239
`2
`
`separated with a resolving power of 1 base by electrophoresis. In electrophoresis, wide use
`is made of a slab gel wherein acrylamide is polymerized between two glass plates separated
`by an interval of approximately 0.3 mm. When the sample is injected at the upper end of
`the slab gel, and an electric field is applied to the upper and lower ends of the slab gel, the
`sample migrates toward the lower end while separating. When a position approximately 30
`cm from the upper end is irradiated by a laser while conducting electrophoresis, separated
`fluorescently labeled fragments are excited as they pass the position of laser irradiation, in
`order from the shorter to the longer. When the emitted fluorescence is measured while
`being spectrally separated with the use of multiple filters, the terminal base types of all of
`the fragments can be determined, in order, from the shorter fragments to the longer, based
`on the change over time in the fluorescent intensity of the four types of fluorophore. With
`the order of these base types being in a complementary relationship with the sample DNA,
`the base sequence of the sample DNA can be determined.
` A number of new DNA base sequence determination methods have been proposed
`which do not employ electrophoresis. With a first prior art, when a complementary-chain
`elongation reaction is conducted by polymerase using the sample DNA as a template, four
`types of base are added, in order, one at a time, and the base quantity incorporated into the
`complementary chain at each step is quantified by photoabsorption or fluorescence,
`whereupon the base sequence of the sample DNA is determined (TOKKAI [Unexamined
`Patent Application] No. H4-505251/1992, gazette). With a second prior art, using the
`sample DNA as a template, and employing four types of base labeled mutually differently,
`a complementary-chain elongation reaction is conducted by polymerase, after which one
`base at a time is released from the 3ƍ end of the complementary chain synthesized by
`exonuclease, and the labels of the released bases are measured, in order, to determine the
`base sequence of the sample DNA (Journal of Biomolecular Structure & Dynamics 7, 301 –
`309 (1989)). With a third prior art, the base sequence of sample DNA is determined by
`repeating a cycle of steps, namely a step for conducting a DNA polymerase reaction using
`four types of dNTP derivative (MdNTP) having labels that can be detected, and that,
`incorporated into a template DNA as DNA polymerase substrate, can stop a DNA chain
`elongation reaction by the presence of a protective group, a step for then detecting the
`MdNTP incorporated, and a step for returning the MdNTP to an elongatable state. With this
`prior art, DNA chain elongation is stopped at the point in time when one base is elongated,
`oxygen and the substrate are removed from the system (solution) wherein the template,
`primer, and MdNTP are present, the MdNTP incorporated is detected, the protective group
`(and label) of the MdNTP incorporated into the template are released, and a condition is
`induced wherein DNA chain elongation is possible (Pat. Applic. No. H2-57978/1990).
`However, these proposals are at present in the idea stage, and there are no reports of them
`having been made practicable.
`
`Disclosure of Invention
`
` Currently, insofar as practical methods of determining DNA base sequences are
`concerned, separation by molecular weight is conducted by electrophoresis. For DNA base
`sequence determination, a resolving power of 1 base length is required for separation by
`
`Exhibit No. 1011
`Page 4
`
`Page 4
`
`

`

`WO 98/33939 PCT/JP97/00239
`3
`
`molecular weight. The resolving power of electrophoresis ordinarily declines as the lengths
`of the bases to be separated become longer. That is, even though one base length can be
`separated between a base length of 50 bases and one of 51 bases, that does not mean that
`one base length can be separated between a base length of 500 bases and one of 501 bases.
`How long of a base length can be resolved by 1 base length, that is, the limit of base length
`separation, is determined by the electrophoresis conditions, that is, the composition of the
`separation medium, the electrophoresis path length, and the electric field intensity. In order
`to increase the limit of base length separation, various optimizations have been
`implemented to date, but there are no reports of a limit exceeding a length of 1000 bases
`(Electrophoresis 13, 495 – 499 (1992), Electrophoresis 13, 616 – 619 (1992)). The
`maximum of 1000 bases for the limit of base length separation has been theoretically
`explained (Electrophoresis 13, 574 – 582 (1992)). That is, insofar as electrophoresis is
`employed, the maximum length at which the base sequence can be determined from one
`sample DNA is a length of 1000 bases. With large-scale base sequence determination
`typified by genome analysis, on the other hand, the limit of base length separation holds the
`key to analytical efficiency (Science 254, 59 – 67 (1991)). The YAC clone, which is a
`typical large clone, for example, has a base length of approximately 1M bases, wherefore, a
`minimum of 1000 samples must be analyzed in order to analyze each base length of 1000
`bases. However, it is not possible to prepare fragments one by one having a base length of
`1000 bases, in order, from the end of a long DNA, without either excess or insufficiency. In
`practice, random fragments are prepared, these are randomly analyzed, and the base
`sequence of the original long DNA is reconfigured using overlaps in the base sequences of
`the fragments. This method, called the shotgun method, is the most widely used method
`today in genome analysis. However, in order to impart overlaps to random fragments so as
`to enable reconfiguration, it is necessary to repeatedly analyze the same base sequence,
`over and over, which is a problem.
`
`The degree of this overlapping, which is called redundancy, increases as the base length
`wherewith one-time base sequence determination is possible becomes smaller, that is, as
`the limit of base length separation in electrophoresis becomes smaller. For a limit of base
`length separation of 1000 bases, a redundancy of approximately 10 is required. That is, it is
`necessary to conduct base sequence determination for a length that is 10 times that of the
`DNA for which the base sequence is to be determined. As a consequence, one must analyze
`approximately 10,000 samples in order to determine the base sequence for a base length of
`1M bases. The number of samples that can be analyzed in one day by one DNA base
`sequence determination device is 100 at most. To determine the base sequence of the entire
`base length of 1M bases with one apparatus would require 100 days. In order to practically
`conduct genome analysis, or the genetic diagnostics the importance whereof will increase
`in future, requires art whereby base sequences 1M bases long can be determined in a few
`days.
` Another problem with the prior art is the necessity therewith of having many DNA
`samples in order to determine base sequences. In order to conduct the dideoxy reactions
`with the Sanger method, a DNA sample of approximately 10í12 mol is ordinarily needed for
`one sample. For that reason, it is necessary to refine and amplify sample DNA beforehand,
`using techniques such as cloning or PCR. Such procedures require time and effort, and
`
`Exhibit No. 1011
`Page 5
`
`Page 5
`
`

`

`WO 98/33939 PCT/JP97/00239
`4
`
`constitute a large rate-limiting process which impedes the progress of genome analysis. In
`order to advance genome analysis and genetic diagnostics efficiently, art is wanted
`wherewith base sequences can be determined from a small quantity of sample DNA, and,
`ultimately, even from a single DNA molecule. The DNA base sequence determination
`methods proposed thus far which do not use electrophoresis are, however, subject to the
`following shortcomings.
`
`In the first prior art example, four types of nucleotide substrate are added, in order, one
`at a time, making it necessary to repeatedly alter the composition of the solution wherein
`the complementary-chain elongation reaction is being conducted. When changing the base
`type in a solution, moreover, cleaning is necessary in order to prevent the admixture of
`another type of base. As a consequence, at least eight solution replacements are required for
`every cycle. Because, ordinarily, one base is determined each cycle, on average, eight
`solution replacements will considerably reduce the speed of base sequence determination.
`The most fundamental problem with the first prior art is that the quantity of signals to be
`quantified accumulates as the complementary chain lengthens, making it extremely difficult
`to measure the changes in signal quantity corresponding to the incorporation of one base. In
`other words, determining the base sequences of DNA having long base length is very
`difficult.
` With the second prior art, four types of base labeled with four types of fluorophore are
`incorporated into the complementary chain, but this is technically very difficult. As will be
`discussed subsequently, because the fluorescence quantity is large, or because the
`molecular size of the fluorophores that can mutually be distinguished by fluorescent
`spectral separation, is large, it is very difficult, due to steric hindrance, for a plurality of
`fluorescently labeled nucleotides to be incorporated next to each other in the same
`complementary chain. Another problem with the second prior art is that it is very difficult
`to control the release of one base at a time using exonuclease. When a plurality of bases has
`been released continuously within a range equal to or less than the detection limitation time,
`the released bases are all detected simultaneously, so the order of base release, which is to
`say the base sequence, cannot be determined. In order to determine the base sequence, it is
`necessary for the release of each base to occur at some interval of time, and not
`continuously, but effecting such control is extremely difficult.
` With the third prior art example, it is necessary, in the step for detecting the MdNTP
`incorporated into the template, and in the step for returning the MdNTP to an elongatable
`condition, to remove MdNTP not incorporated into the template from the solution, and also
`to add MdNTP into the solution at the point in time when the next, new, cycle starts. When
`this is neglected, the signals from the MdNTP incorporated into the template and the
`signals from the MdNTP not incorporated into the template become mixed, whereupon the
`signals from the MdNTP incorporated into the template targeted cannot be accurately
`measured. Furthermore, when the protective groups of MdNTP not incorporated into the
`template are also released, and dNTP from which the protective group has been released is
`incorporated into the template, the prescribed cycle ceases to advance. As a consequence, a
`minimum of two solution content changes will be necessary for each cycle, which causes
`the speed of base sequence determination to be retarded. Thus, when the change in solution
`content is incomplete, and the slightest amount of MdNTP not incorporated into the
`
`Exhibit No. 1011
`Page 6
`
`Page 6
`
`

`

`WO 98/33939 PCT/JP97/00239
`5
`
`template remains in the solution, that causes a lot of noise when conducting measurements,
`which is a problem.
` An object of the present invention is to provide a method and an apparatus for
`determining the base sequences of very long DNA [chains] by determining the types of
`bases of nucleotides incorporated when conducting complementary-chain elongation
`reactions by polymerase, in order, one at a time, in order to resolve the problems with the
`DNA base sequence determination methods proposed to date which do not employ
`electrophoresis.
` With the present invention, a single template DNA molecule (sample) is held within the
`field of view of a fluorescence microscope, complementary-chain elongation is conducted,
`under control, one base at a time, and each fluorescently labeled base incorporated is
`subjected to single molecular measurement. In performing DNA base sequencing, it is only
`necessary to monitor, one by one, the types of bases of nucleotides incorporated in the
`complementary-chain elongation reaction by polymerase. There are two conditions, namely
`(1) that the elongation reaction not advance after one nucleotide has been incorporated, and
`(2), that, after determining the base type of the one nucleotide incorporated, incorporation
`of the next single nucleotide be made possible, that all nucleotides to be incorporated must
`be chemically modified so as to simultaneously satisfy. These two conditions can be
`achieved by combining nucleotides, on the one hand, and caged compounds having
`fluorophores as labels, on the other, for example. Caged compounds are compounds that
`mask residues contributing to the activity of physiologically active substances by the
`nitrobenzyl group or the like, and cause the dissociation of modifying groups by photo-
`irradiation. For example, a caged compound is a substance wherein the 2-nitrobenzyl group
`has been introduced, which 2-nitrobenzyl group is released by UV irradiation. This
`procedure is widely used in the field of biology (Annu. Rev. Biophys. Biophys. Chem. 18,
`239 – 270 (1989)). Many different kinds of caged compound are sold by companies such as
`Molecular Probes, Inc. The chemically modified nucleotides used in the present invention,
`as diagrammed in Fig. 1, are caged compounds wherein a 2-nitrobenzyl group is bonded to
`a physiologically active substrate X (a nucleotide), and have the capability to suppress the
`inherent activity of chemically modified nucleotides, that is, of the activity of being
`continually incorporated by complementary chain synthesis reactions, the ability to release
`the caged substance (2-nitrobenzyl group) when subjected to UV irradiation at 360 nm or
`below, and to convert [the chemically modified nucleotides] to a substrate X or HX
`exhibiting inherent physiological activity. In Fig. 1, R is H or an alkyl group (such as CH3)
`or the like.
`
`The method of manufacturing Texas Red-labeled caged dGTP, as an example of a
`chemically modified nucleotide having the capabilities noted above, is diagrammed in Figs.
`3 to 7. In Fig. 3, water-soluble carbodimide (HOOC (CH2)2 COOH) is reacted with a
`derivative of dGTP (Fig. 2) that is a starting substance when chemically modifying a base
`(Science 238, 336 – 341, 1987), to obtain a dGTP derivative having a carboxyl group as a
`linker end. As diagrammed in Fig. 4, on the other hand, nitric acid is reacted with 2-
`nitroacetophenon (Aldrich, N920-9), a nitro group is inducted at the carbon 4 position, and
`that nitro group is reduced to convert it to an amino group. As diagrammed in Fig. 5, the
`compound on the left side in Fig. 4 is reacted with Texas Red (Molecular [sic] Probes, T-
`
`Exhibit No. 1011
`Page 7
`
`Page 7
`
`

`

`WO 98/33939 PCT/JP97/00239
`6
`
`353), causing it to bond. Then, as diagrammed in Fig. 6, NH2íNH2 is reacted with the
`compound on the right side in Fig. 5, MnO2 is further reacted therewith, and the
`acetophenone of the compound on the left side in Fig. 6 is converted to a diazoethane group
`(J. Am Chem. Soc. 110, 7170 – 7177, (1998)). The compounds on the right side in Figs. 3
`and 6 are reacted, whereupon, as diagrammed in Fig. 7, a fluorescently labeled (Texas Red)
`caged nucleotide (dGTP) is obtained that is dGTP wherein a 2-nitrobenzyl group to which
`Texas Red has been bound as a label has been introduced. For other base types also,
`fluorescently labeled caged nucleotides (nucleotides to which are bound caged compounds
`to which a fluorescent label has been attached) can be synthesized.
` As seen in the substance diagrammed in Fig. 7, substances labeled at the position of the
`base of the nucleotide can be incorporated by polymerase-based complementary-chain
`elongation reactions, as has been confirmed by various experiments. It has been confirmed,
`for example, that dideoxy nucleotide ddNTPs, the positions of the bases whereof are
`labeled by various fluorophores, that is, that the terminators of the complementary chain
`synthesis, are incorporated by complementary chain synthesis (Nucleic Acids Respectively.
`20, 2471 – 2483 (1992)). When the molecular size of the fluorophore is large, steric
`hindrance occurs, so two or more fluorescently labeled deoxynucleotides are not
`incorporated continuously (Anal. Biochem. 234, 166 – 174 (1996)). That is, a
`deoxynucleotide labeled by a comparatively large fluorophore, as diagrammed in Fig. 7,
`can be incorporated by complementary chain synthesis, but, once it has been incorporated,
`all further complementary chain elongation will cease. When the compound diagrammed in
`Fig. 7 is subjected to UV irradiation at 360 nm or below, the chemical structure changes
`according to the photochemical reaction diagrammed in Fig. 1, as diagrammed in Fig. 8,
`and caged substances with a fluorophore attached are released from the positions of the
`bases of the compound diagrammed in Fig. 7. If the like reaction is brought about with a
`complementary chain incorporated, steric hindrance will be eliminated, and the
`complementary chain will again be elongated. At that time, the linker portion remains in the
`base, as diagrammed in Fig. 8, but, because the size of that linker portion is small,
`complementary-chain elongation is not affected.
`
`That is, if polymerase complementary-chain elongation reactions are conducted with
`the Texas Red-labeled caged dGTP diagrammed in Fig. 7, and caged dATP, dCTP, and
`dTTP are labeled with different fluorophores, as substrates, the one-base-at-a-tie elongation
`reaction described above can be controlled, and the type of base incorporated can also be
`identified by fluorescence measurement. With fluorescence measurement, excitation laser
`irradiation is conducted, and, in order to excite only the incorporated nucleotides while not
`exciting the other suspended nucleotides, laser irradiation is conducted after spatially
`separating the two, or the evanescent irradiation described subsequently is used. By
`repeating the steps described above, that is, (1) incorporating one fluorescently labeled
`caged nucleotide using polymerase, (2) exciting the incorporated fluorescent label
`incorporated by laser irradiation, (3) spectrally separating the emitted fluorescence and
`determining the type of base from the type of fluorophore, and (4) releasing the
`fluorescently labeled caged substance by a photochemical reaction through UV irradiation,
`the fluorescently labeled caged nucleotides can be incorporated one by one, using
`polymerase, whereupon the base sequence of the template DNA is determined.
`
`Exhibit No. 1011
`Page 8
`
`Page 8
`
`

`

`WO 98/33939 PCT/JP97/00239
`7
`
` Next, the single molecule measurement that detects fluorescence from the fluorophore
`labeling one incorporated nucleotide is described. Fig. 9 is a simplified diagram of the
`configuration of the main components of an apparatus for conducting this single molecule
`measurement. Because single molecule measurement is extremely abhorrent of all
`impurities and contamination and such like, all procedures are conducted in a clean room,
`paying particularly close attention to all optical systems. A cell filled with a buffer solution
`is placed above the objective lens of an inverted fluorescence microscope, and the sample
`DNA 7 that is to be the template is held, by the technique described below, in the buffer
`solution, inside the field of view of the fluorescence microscope. The position wherein the
`sample DNA is held is brought close to the upper surface inside the cell, and the distance
`from that upper surface is maintained at 100 nm or less. A prism 4 is disposed at the upper
`surface outside the cell. An excitation laser beam 1 is introduced from the upper right,
`obliquely through the prism 4, perfectly reflected by the upper surface inside the cell, and
`conducted toward the upper left, obliquely through the prism 4 once again. When this is
`done, exciting light called evanescent waves 13 slightly infiltrates the buffer solution in the
`cell in the vicinity of the upper surface thereof. The intensity of this exciting light
`diminishes exponentially as the distance from the upper surface inside the cell increases.
`When a 515 nm Ar laser is used, the intensity will be 1/e at a position separated
`approximately 150 nm from the upper surface. This irradiation method is called the
`evanescent irradiation method. If this evanescent irradiation method is employed, only
`substances present within 150 nm of the surface inside the cell will be excited, background
`light from fluorescence measurement, such as water Raman scattering, can be reduced to
`almost nothing, and single molecule fluorescence measurement can be performed (Nature
`374, 555 – 559 (1995)). The emitted fluorescence is monitored as a fluorescence
`microscopic image by a supersensitive two-dimensional camera through the objective lens
`from below the cell. One fluorescently labeled nucleotide (fluorescently labeled caged
`nucleotide) 9 incorporated by a polymerase reaction 10, with a primer 8 as the origin, is
`fixed in the template DNA 7, wherefore the fluorescence is observed as a bright spot in a
`two-dimensional image.
` On the other hand, because suspended fluorescently labeled nucleotides that are not
`incorporated move vigorously about the cell three-dimensionally due to Brownian motion,
`the fluorophores are not observed one by one in the two-dimensional image as bright spots,
`but appear as an overall increase in background light. Because the space wherein the
`fluorophores are excited is limited to the minute range of 150 nm or less from the surface
`within the cell, the amount of increase in background light is small, and single molecule
`observation of the fluorophores fixed to the template DNA can be accomplished. The two-
`dimensional image is divided into four by a prism disposed above a light-receiving optical
`system, and passed through different filters, whereupon the type of fluorophore is identified
`at the moment of detection, and, thereby, the type of incorporated nucleotide base is also
`determined. This fluorescence selection method is described in detail in TOKKAI H2-
`269936/1990, gazette. The evanescent irradiation method is also used in like manner when
`releasing the fluorescently labeled caged substance of the incorporated nucleotide 9. The
`UV pulse laser beam 2 is conducted obliquely from upper right through the prism 4,
`perfectly reflected by the upper surface of the cell, and then conducted obliquely toward the
`
`Exhibit No. 1011
`Page 9
`
`Page 9
`
`

`

`WO 98/33939 PCT/JP97/00239
`8
`
`upper left, again through the prism 4. The range within 150 nm from the surface inside the
`cell is UV-irradiated, and the fluorescently labeled caged substance of the incorporated
`nucleotide is selectively released. At that time, it is possible that the fluorescently labeled
`caged substance of an extremely small number of suspended nucleotides that happen to be
`within the range of 150 nm or less from the surface within the cell will also be released, and
`that non-chemically modified nucleotides that are generated will be incorporated in the
`subsequent polymerase reaction. In order to reduce that possibility to zero, the buffer
`solution in the cell is continually made to flow in one direction so that fresh buffer solution
`is constantly supplied.
` Next, the configuration for holding a single molecule of template DNA 7 within the
`field of view of the fluorescence microscope is described. To the two ends of the

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket